Citation Impact

Citing Papers

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
2010
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
2011
Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients
2007
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
De novo design of self-assembling helical protein filaments
2018 StandoutScienceNobel
Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States
2014
Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid
2008
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans
2019 StandoutNobel
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
2014 Standout
The effect and acceptability of tympanometry and pneumatic otoscopy in general practitioner diagnosis and management of childhood ear disease
2014
A Case of Imported Melioidosis Presenting as Prostatitis
2003
Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
2014
Aspergillosis: Spectrum of Disease, Diagnosis, and Treatment
2006
Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance
2004
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT
2011
Cerebral melioidosis in Singapore: a review of five cases
2002
Invasive Mycoses: Diagnostic Challenges
2011
Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings
2014
1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia
2008
Invasive Fungal Infections
2013
The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts
2011
Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
2006
Galactomannan Antigenemia in Pediatric Oncology Patients With Invasive Aspergillosis
2008
Nasal Carriage as a Source ofStaphylococcus aureusBacteremia
2001 Standout
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases
2015 Standout
Approach to the Diagnosis of Invasive Aspergillosis and Candidiasis
2009
Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay
2005
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study
2001
Low occurrence of Pseudomonas aeruginosa in agricultural soils with and without organic amendment
2014
Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area
2002
Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies
2010
Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients
2011
Supervised classification of human microbiota
2010
Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model
2013
Local Anti‐Infective Therapy: Pharmacological Agents. A Systematic Review
2003
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Galactomannan detection for invasive aspergillosis in immunocompromized patients
2008
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
2007
Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
2014
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
A survey of anti-fungal management in lung transplantation
2004
Probable Invasive Aspergillosis without Prespecified Radiologic Findings: Proposal for Inclusion of a New Category of Aspergillosis and Implications for Studying Novel Therapies
2010
AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
2015
Prospective Aspergillus Galactomannan Antigen Testing in Pediatric Hematopoietic Stem Cell Transplant Recipients
2007
Intravascular catheter-related infections: advances in diagnosis, prevention, and management
2007
Characterisation of the mob locus from Rhodobacter sphaeroides required for molybdenum cofactor biosynthesis
1998
Melioidosis
2012 Standout
Resin composite—State of the art
2010 Standout
Serum and Bronchoalveolar Lavage Fluid Galactomannan Assays in Patients with Pulmonary Aspergilloma
2011
Diagnostic value of the serum galactomannan assay for invasive aspergillosis: It is less useful in non-haematological patients
2012
The global distribution of Burkholderia pseudomallei and melioidosis: an update
2008
Pseudomonas aeruginosa Exhibits Frequent Recombination, but Only a Limited Association between Genotype and Ecological Setting
2012
Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients: Increasing Antigenemia Is Associated with Progressive Disease
2002
Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect
2016 Standout
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study
2012
Effect of material characteristics and/or surface topography on biofilm development
2006 Standout
False‐Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin‐Tazobactam
2004
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
2010
Pathogenic Mechanisms and Host Interactions in Staphylococcus epidermidis Device-Related Infection
2017
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis
2013
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
2005
Prospective clinical evaluation of a LightCyclerTM‐mediated polymerase chain reaction assay, a nested‐PCR assay and a galactomannan enzyme‐linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients
2004
Strong Correlation between Serum Aspergillus Galactomannan Index and Outcome of Aspergillosis in Patients with Hematological Cancer: Clinical and Research Implications
2008
 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
2011
Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis
2003
Metazoan MicroRNAs
2018 Standout
Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa
2005
Diagnostic Performance of the (1→3)‐β‐ d ‐Glucan Assay for Invasive Fungal Disease
2009
Aspergillosis
2002
Issues with galactomannan testing
2006
Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
2009
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
2004
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Cigarette Smoke Decreases Airway Epithelial FABP5 Expression and Promotes Pseudomonas aeruginosa Infection
2013
Staphylococcus epidermidis — the 'accidental' pathogen
2009
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation
2010
Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection
2004
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure
2012
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
Graft-versus-host disease
2009 Standout
Echinocandin antifungal drugs
2003 Standout
Rapid diagnosis of invasive aspergillosis by antigen detection
2003
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT
2008
Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children
2014
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
2011
Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies
2005
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Usefulness of Sequential Aspergillus galactomannan Antigen Detection Combined With Early Radiologic Evaluation for Diagnosis of Invasive Pulmonary Aspergillosis in Patients Undergoing Allogeneic Stem Cell Transplantation
2006
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
2002 Standout
Autoinducer-2 increases biofilm formation via an ica- and bhp-dependent manner in Staphylococcus epidermidis RP62A
2015
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition
2011
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
2013
Towards the directed evolution of protein materials
2019
Fluconazole-Resistant Candida albicans Vulvovaginitis
2012
The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis
2013
Prospective Assessment of Platelia™Aspergillus Galactomannan Antigen for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients
2004
Update on Infective Endocarditis
2006
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Treatment with Piperacillin‐Tazobactam and False‐PositiveAspergillusGalactomannan Antigen Test Results for Patients with Hematological Malignancies
2004
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis
2008
Periodontal diseases
2005 Standout
Pseudomonas aeruginosa: a formidable and ever-present adversary
2009
Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial
2004
Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts
2007
Effectiveness of mechanical nonsurgical pocket therapy
2005
Melioidosis in 6 Tsunami Survivors in Southern Thailand
2005
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study
2011
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
High Resolution Computed Tomography Angiography Improves the Radiographic Diagnosis of Invasive Mold Disease in Patients With Hematological Malignancies
2015
Detection of (1, 3)-β-d-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts
2012
Advances and challenges in management of invasive mycoses
2005
Empirical antifungal therapy in selected patients with persistent febrile neutropenia
2009
Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease
2010
Burden of Disease Caused by Otitis Media: Systematic Review and Global Estimates
2012 Standout
 -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)
2011
Infection in Solid-Organ Transplant Recipients
2007 Standout
Effect of Non‐Surgical Periodontal Therapy on Glycemic Control in Patients with Type 2 Diabetes Mellitus
2003
Pseudomonas aeruginosa core metabolism exerts a widespread growth-independent control on virulence
2020
Clinical evaluation of Aspergillus‐PCR for detection of invasive aspergillosis in immunosuppressed patients
2005
Evaluation of Serum Sandwich Enzyme-Linked Immunosorbent Assay for Circulating Galactomannan during Caspofungin Therapy: Results from the Caspofungin Invasive Aspergillosis Study
2005
Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis
2015
DETECTION OF ASPERGILLUS GALACTOMANNAN BY ENZYME IMMUNOABSORBENT ASSAY IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PROSPECTIVE STUDY
2004
Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center
2011
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
2013
Fungal endocarditis
2004
Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis
2011
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
2004
A Randomized and Prospective Study of 3 Procedures for the Diagnosis of Catheter-Related Bloodstream Infection without Catheter Withdrawal
2007
Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis
2008
In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis
2002
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
2009
Phosphine‐Initiated General‐Base‐Catalyzed Quinolone Synthesis
2014
Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis
2010
Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections
2010
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Fever of Unknown Origin in Febrile Leukopenia
2007
A retrospective series of gut aspergillosis in haematology patients
2010
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
2012
Invasive Aspergillosis in Critically Ill Patients without Malignancy
2004
Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis
2014
Index to Predict Invasive Mold Infection in High-Risk Neutropenic Patients Based on the Area Over the Neutrophil Curve
2009
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
2009
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Prognostic value of serum galactomannan index in critically ill patients with chronic obstructive pulmonary disease at risk of invasive pulmonary aspergillosis
2014
Comparison of Non-Culture-Based Methods for Detection of Systemic Fungal Infections, with an Emphasis on Invasive Candida Infections
2005
Peptide Antimicrobial Agents
2006 Standout
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Differential Time to Positivity: A Useful Method for Diagnosing Catheter-Related Bloodstream Infections
2004
Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity
2012
Empirical Amphotericin B therapy on Day 4 or Day 8 of Febrile Neutropenia
2013
Diagnosing Invasive Aspergillosis during Antifungal Therapy by PCR Analysis of Blood Samples
2004
opm: an R package for analysing OmniLog® phenotype microarray data
2013
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Polysialic Acid, a Glycan with Highly Restricted Expression, Is Found on Human and Murine Leukocytes and Modulates Immune Responses
2008 StandoutNobel
Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical Implications
2002
AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
2002
Laboratory diagnosis of invasive candidiasis.
2005
Prevention and Treatment of Cancer-Related Infections
2012
Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis
2012
Breastfeeding and childhood acute otitis media: a systematic review and meta‐analysis
2015
Differential Effects of Levofloxacin and Ciprofloxacin on the Risk for Isolation of Quinolone-Resistant Pseudomonas aeruginosa
2006
Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia
2002
Laboratory diagnosis of invasive aspergillosis
2005
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Phosphine Organocatalysis
2018 Standout
AspergillusInfections in Transplant Recipients
2005
Follow-Up of Staphylococcus aureus Nasal Carriage after 8 Years: Redefining the Persistent Carrier State
1999
Environmental reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa
2018
Meta-Analysis: Methods for Diagnosing Intravascular Device–Related Bloodstream Infection
2005
Using the shortwave infrared to image middle ear pathologies
2016 StandoutNobel
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
2003
Invasive Candidiasis
2015 Standout
Effect of MexXY Overexpression on Ceftobiprole Susceptibility in Pseudomonas aeruginosa
2009
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Use and Limits of (1-3)-β- d -Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis
2014
Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegansPseudomonas aeruginosa Infection Model
2017
Failure To Detect Circulating Aspergillus Markers in a Patient with Chronic Granulomatous Disease and Invasive Aspergillosis
2000
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Bloodstream Infection in Neutropenic Cancer Patients Related to Short-Term Nontunnelled Catheters Determined by Quantitative Blood Cultures, Differential Time to Positivity, and Molecular Epidemiological Typing with Pulsed-Field Gel Electrophoresis
2003
Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients.
2005
Aspergillosis of bones and joints – a review from 2002 until today
2014
Utility of Galactomannan Enzyme Immunoassay and (1,3) β- d -Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients
2008
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
2013
Aspergillus Galactomannan Antigen in the Cerebrospinal Fluid of Bone Marrow Transplant Recipients with Probable Cerebral Aspergillosis
2002
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Assessment of the clinical utility of serial β-d-glucan concentrations in patients with persistent neutropenic fever
2008
Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis
2003
Diagnostic Accuracy of Serum 1,3-β- d -Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis
2011
Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia
2001
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
2009
Aminoglycoside Resistance inPseudomonas aeruginosa
2005
Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum
2004
Inactivation of the miR-183/96/182 Cluster Decreases the Severity of Pseudomonas aeruginosa -Induced Keratitis
2016
The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response
2016
The Mononuclear Molybdenum Enzymes
2014 Standout
Contribution of (1→3)-β- d -Glucan Chromogenic Assay to Diagnosis and Therapeutic Monitoring of Invasive Aspergillosis in Neutropenic Adult Patients: a Comparison with Serial Screening for Circulating Galactomannan
2005
Versatility of Biofilm Matrix Molecules in Staphylococcus epidermidis Clinical Isolates and Importance of Polysaccharide Intercellular Adhesin Expression during High Shear Stress
2016
Clinical significance of non‐surgical periodontal therapy: an evidence‐based perspective of scaling and root planing
2002
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
2007
Caenorhabditis elegans responses to bacteria from its natural habitats
2016 StandoutNobel
Real-Time PCR Coupled with Automated DNA Extraction and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis
2002
Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa
2006
Evolution Stings: The Origin and Diversification of Scorpion Toxin Peptide Scaffolds
2013
Comparison of surface roughness of oral hard materials to the threshold surface roughness for bacterial plaque retention: A review of the literature
1997 Standout
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain
2009
Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β- d -Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders
2004
Bifidobacterial Lipoglycan as a New Cause for False-Positive Platelia Aspergillus Enzyme-Linked Immunosorbent Assay Reactivity
2005

Works of Johan Van Eldere being referenced

Otitis media and its consequences: beyond the earache
2010
Optimization of the Cutoff Value for the Aspergillus Double-Sandwich Enzyme Immunoassay
2007
Vaccination with SesC Decreases Staphylococcus epidermidis Biofilm Formation
2012
Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
2009
Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients
2008
Polyclonal Staphylococcal Endocarditis Caused by Genetic Variability
2000
Antibacterial and antifungal properties of α‐helical, cationic peptides in the venom of scorpions from southern Africa
2002
Genomic Copy Number Determines Functional Expression of β-Defensin 2 in Airway Epithelial Cells and Associates with Chronic Obstructive Pulmonary Disease
2010
Full‐ versus partial‐mouth disinfection in the treatment of periodontal infections
1996
Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)
2008
The influence of abutment surface roughness on plaque accumulation and peri‐implant mucositis
1996
Detection and characterization of class A extended-spectrum- -lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals
2010
Region II of the Haemophilus influenzae Type b capsulation locus as involved in serotype‐specific polysaccharide synthesis
1995
Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium—update (1994–98)
2000
The rôle of chlorhexidine in the one‐stage full‐mouth disinfection treatment of patients with advanced adult periodontitis
2000
Otitis media and its consequences: beyond the earache
2010
Melioidosis Brain and Lung Abscess After Travel to Sri Lanka
1999
Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river
2005
Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter—related infections
2003
Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients
2002
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders
2007
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
2007
Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients
2001
Expression of Biofilm‐Associated Genes inStaphylococcus epidermidisduring In Vitro and In Vivo Foreign Body Infections
2003
One Stage Full‐ Versus Partial‐Mouth Disinfection in the Treatment of Chronic Adult or Generalized Early‐Onset Periodontitis.
1999
Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
2005
Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections
2003
Pseudomonas aeruginosa Population Structure Revisited
2009
Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients
2004
Comparison of VITEK 2 with ITS2-Fragment Length Polymorphism Analysis for Identification of Yeast Species
2004
Clonal analysis and identification of epidemic strains of methicillin-resistant Staphylococcus aureus by antibiotyping and determination of protein A gene and coagulase gene polymorphisms
1997
Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis
1999
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
2001
Serum (1-3)-β- d -Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy
2009
Protein aggregation in bacteria: the thin boundary between functionality and toxicity
2013
The role of σ B in persistence of Staphylococcus epidermidis foreign body infection
2008
The influence of titanium abutment surface roughness on plaque accumulation and gingivitis: short-term observations.
1996
Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test
1996
Origin and transmission of methicillin-resistant Staphylococcus aureus in an endemic situation: differences between geriatric and intensive-care patients
1997
Risk Factors for Development of Multiple-Class Resistance to Streptococcus pneumoniae Strains in Belgium over a 10-Year Period: Antimicrobial Consumption, Population Density, and Geographic Location
2007
Inhibition of Staphylococcus epidermidis Biofilm Formation by Rabbit Polyclonal Antibodies against the SesC Protein
2009
Rankless by CCL
2026